Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial.

about

Soy and Health Update: Evaluation of the Clinical and Epidemiologic Literature Nutraceutical approaches to metabolic syndrome.Anti-Inflammatory and Anti-Obesity Properties of Food Bioactive Components: Effects on Adipose Tissue.

P2860

Q28071946-3D967443-D626-459B-92BB-9200442DF06F Q47979569-5348F97A-23DA-4437-AD8E-8E89FDFEBFA5 Q49627347-0EEA1CD5-FD28-4774-956B-5A8031CA7A65

P2860

Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial.

Item

http://www.wikidata.org/entity/Q39273397

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Effect of soy on metabolic syn ...... a randomized controlled trial.

@en

Effect of soy on metabolic syn ...... a randomized controlled trial.

@nl

type

Item

label

Effect of soy on metabolic syn ...... a randomized controlled trial.

@en

Effect of soy on metabolic syn ...... a randomized controlled trial.

@nl

prefLabel

Effect of soy on metabolic syn ...... a randomized controlled trial.

@en

Effect of soy on metabolic syn ...... a randomized controlled trial.

@nl

P1476

Effect of soy on metabolic syn ...... a randomized controlled trial.

@en

P2093

Beatrice Morlotti

http://www.w3.org/2001/XMLSchema#string

Cecilia Vitali

http://www.w3.org/2001/XMLSchema#string

Cesare R Sirtori

http://www.w3.org/2001/XMLSchema#string

Laura Calabresi

http://www.w3.org/2001/XMLSchema#string

Raffaella Bosisio

http://www.w3.org/2001/XMLSchema#string

P2860

General and Abdominal Adiposity and Risk of Death in Europe

Hypocholesterolaemic effects of soya proteins: results of recent studies are predictable from the anderson meta-analysis data.

Characterization and quantification of soy isoflavone metabolites in serum of renal transplanted patients by high-performance liquid chromatography/electrospray ionization mass spectrometry.

Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial.

Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors.

Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms.

Soy components vs. whole soy: are we betting our bones on a long shot?

Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol.

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

Role of dietary soy protein in obesity

P2888

s00394-016-1333-7

P304

499-511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00394-016-1333-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27757595

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial.

about

P2860

P2860

Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921